Upregulation of LPCAT1 has been observed in clear renal cell carcinoma, oral squamous cell carcinoma, hepatoma, esophageal cancers, gastric cancers, breast cancers, colorectal cancers, and prostate cancers [136]. This evidence concerns the gene LPCAT1 and clear cell renal carcinoma.